A study to assess the safety, tolerability, and pharmacokinetics of a single ascending dose of AZD0292 in healthy Japanese participants

Trial Identifier:	D7700C00004
Sponsor:	AstraZeneca
Start Date:	November 2025
Primary Completion Date:	July 2026
Study Completion Date:	July 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.